Listing Title
Listing Category
Description
MOMENTOUS is a multi-center, randomized study to prospectively evaluate the performance of an ECG-based AI device to predict whether participants with interstitial lung disease (ILD) are at high risk of undiagnosed pulmonary hypertension.
Study Status
Upcoming Trial
Trial Documentation:
Principal Investigator
Dr. Eric Weaver, StatCare Medical Group
Listing Title
Listing Category
Description
The purpose of this study is to assess the efficacy and safety of the study drug, levosimendan (given orally), compared to placebo in participants with pulmonary hypertension with heart failure with preserved left ventricular ejection fraction (PH-HFpEF) as measured by the change in 6-Minute Walk Distance. Participants will be eligible for an open label extension (OLE) of 52 weeks.
Study Status
Upcoming Trial
Trial Documentation:
Principal Investigator
Dr. John Swisher, StatCare Medical Group